FDA panel urges baby-friendly dosage instructions on acetaminophen (Tylenol) labels
In a unanimous 21-to-0 vote, an FDA advisory panel recommended that the FDA require labels for acetaminophen-containing pain relievers to include weight-based infant dosage instructions to help prevent overdoses. Focusing exclusively on over-the-counter medications whose only active ingredient is acetaminophen, such as Children’s Tylenol and Novartis’ Triaminic, the panel also suggested that dosing instructions for all children should emphasize that weight (as opposed to age) is the best way to determine dose.
